Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents

ObjectivesThe purposes of this study were to evaluate the risk for analytical interference with gadolinium-based contrast agents (GBCAs) for the colorimetric measurement of serum iron (Fe3+) and to investigate the mechanisms involved. Materials and MethodsRat serum was spiked with several concentrations of all molecular categories of GBCAs, ligands, or “free” soluble gadolinium (Gd3+). Serum iron concentration was determined by 2 different colorimetric methods at pH 4.0 (with a Vitros DT60 analyzer or a Cobas Integra 400 analyzer). Secondly, the cause of interference was investigated by (a) adding free soluble Gd3+ or Mn2+ to serum in the presence of gadobenic acid or gadodiamide and (b) electrospray ionization mass spectrometry. ResultsSpurious decrease in serum Fe3+ concentration was observed with all linear GBCAs (only with the Vitros DT60 technique occurring at pH 4.0) but not with macrocyclic GBCAs or with free soluble Gd3+. Spurious hyposideremia was also observed with the free ligands present in the pharmaceutical solutions of the linear GBCAs gadopentetic acid and gadodiamide (ie, diethylene triamine pentaacetic acid and calcium-diethylene triamine pentaacetic acid bismethylamide, respectively), suggesting the formation of Fe-ligand chelate.Gadobenic acid-induced interference was blocked in a concentration-dependent fashion by adding a free soluble Gd3+ salt. Conversely, Mn2+, which has a lower affinity than Gd3+ and Fe3+ for the ligand of gadobenic acid (ie, benzyloxypropionic diethylenetriamine tetraacetic acid), was less effective (interference was only partially blocked), suggesting an Fe3+ versus Gd3+ transmetallation phenomenon at pH 4.0. Similar results were observed with gadodiamide. Mass spectrometry detected the formation of Fe-ligand with all linear GBCAs tested in the presence of Fe3+ and the disappearance of Fe-ligand after the addition of free soluble Gd3+. No Fe-ligand chelate was found in the case of the macrocyclic GBCA gadoteric acid. ConclusionsMacrocyclic GBCAs induced no interference with colorimetric methods for iron determination, whereas negative interference was observed with linear GBCAs using a Vitros DT60 analyzer. This interference of linear GBCAs seems to be caused by the excess of ligand and/or an Fe3+ versus Gd3+ transmetallation phenomenon.

[1]  G. Lippi,et al.  Interference of medical contrast media on laboratory testing , 2014, Biochemia medica.

[2]  V. Runge,et al.  MRI contrast agents: Basic chemistry and safety , 2012, Journal of magnetic resonance imaging : JMRI.

[3]  Uwe Karst,et al.  Speciation of Gd-based MRI contrast agents and potential products of transmetalation with iron ions or parenteral iron supplements , 2012, Analytical and Bioanalytical Chemistry.

[4]  M. Port,et al.  Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide , 2012, British journal of pharmacology.

[5]  Arthur E. Martell,et al.  Critical Stability Constants , 2011 .

[6]  C. Robic,et al.  Erratum to: The role of phosphate on Omniscan® dechelation: an in vitro relaxivity study at pH 7 , 2011, BioMetals.

[7]  Robic Caroline,et al.  The role of phosphate on Omniscan® dechelation: an in vitro relaxivity study at pH 7 , 2011, BioMetals.

[8]  S. Laurent,et al.  How to measure the transmetallation of a gadolinium complex. , 2010, Contrast media & molecular imaging.

[9]  C. Robic,et al.  Role of thermodynamic and kinetic parameters in gadolinium chelate stability , 2009, Journal of magnetic resonance imaging : JMRI.

[10]  S. Morcos,et al.  Interference of gadolinium-based contrast agents with the measurement of serum creatinine by the Jaffe reaction. , 2009, The British journal of radiology.

[11]  T. Frenzel,et al.  Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C , 2008, Investigative radiology.

[12]  C. Robic,et al.  Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review , 2008, BioMetals.

[13]  Sudhir V. Shah,et al.  Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. , 2007, The New England journal of medicine.

[14]  M. Port,et al.  Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review , 2006, Fundamental & clinical pharmacology.

[15]  Sophie Laurent,et al.  Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. , 2006, Contrast media & molecular imaging.

[16]  H. Ersoy,et al.  Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements , 2006, Journal of magnetic resonance imaging : JMRI.

[17]  T. Balzer,et al.  Interference of Gadolinium-Containing Contrast-Enhancing Agents With Colorimetric Calcium Laboratory Testing , 2005, Investigative radiology.

[18]  L. V. Rao,et al.  Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays. , 2004, American journal of clinical pathology.

[19]  Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications. Final rule. , 2003, Federal register.

[20]  S. Laurent,et al.  Stability of MRI Paramagnetic Contrast Media: A Proton Relaxometric Protocol for Transmetallation Assessment , 2001, Investigative radiology.

[21]  M. Port,et al.  Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents. , 1999, Journal of pharmaceutical and biomedical analysis.

[22]  L. Calabi,et al.  Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. , 1999, Journal of computer assisted tomography.

[23]  H. Thomsen,et al.  Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. , 1998, Academic radiology.

[24]  P. Normann,et al.  Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination of serum calcium. , 1995, Scandinavian journal of clinical and laboratory investigation.

[25]  Arthur E. Martell,et al.  Stabilities of trivalent metal ion complexes of the tetraacetate derivatives of 12-, 13- and 14-membered tetraazamacrocycles , 1991 .

[26]  J. Hagan,et al.  Reaction of gadolinium chelates with endogenously available ions. , 1991, Magnetic resonance imaging.

[27]  B. Bonnemain,et al.  Gd-DOTA. Pharmacokinetics and tolerability after intravenous injection into healthy volunteers. , 1990, Investigative radiology.

[28]  Joseph Whitley.  INVESTIGATIVE RADIOLOGY , 1982 .